Related Experiment Video
Updated: Mar 28, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Statin Use and Aneurysm Risk in Patients With Bicuspid Aortic Valve Disease
Alexander P Taylor1, Ajay Yadlapati1, Adin-Cristian Andrei2
1Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Insights
Preoperative statin use may reduce the risk of ascending aortic dilatation in patients with bicuspid aortic valve disease undergoing surgery. This finding suggests a potential medical therapy to manage aortic complications in BAV patients.
Area of Science:
- Cardiology
- Vascular Biology
- Pharmacology
Background:
- Bicuspid aortic valve (BAV) disease is a common congenital heart defect associated with aortic dilatation.
- Currently, no medical therapy effectively prevents the progression of aortic dilatation in BAV disease.
- Surgical intervention remains the primary treatment for significant aortic dilatation in BAV patients.
Purpose of the Study:
- To investigate the association between preoperative statin use and the odds of ascending aortic dilatation in patients with BAV disease referred for surgery.
- To determine if statins could be a potential medical therapy for managing aortic dilatation in BAV.
Main Methods:
- Retrospective review of 680 BAV patients who underwent aortic surgery between 2004 and 2013.
- Aortic diameter (AD) was measured, and patients were categorized into maximal AD <4.5 cm or ≥4.5 cm groups.
- Multivariable logistic regression analysis was used to assess the association between preoperative statin use and aortic dilatation, adjusting for clinical factors.
Main Results:
- Patients with larger ascending aortic diameters (≥4.5 cm) were less likely to be on preoperative statins (35%) compared to those with smaller diameters (<4.5 cm, 45%).
- After adjusting for covariates, preoperative statin use was associated with 0.66 times lower odds of having significant ascending aortic dilatation (AD ≥4.5 cm).
- This association was statistically significant (P = 0.029).
Conclusions:
- Preoperative statin use is associated with reduced odds of clinically significant ascending aortic dilatation in patients with bicuspid aortic valve disease.
- These findings suggest a potential role for statins in managing aortic dilatation in BAV patients, warranting further investigation.
- This study highlights a possible medical adjunctive therapy to surgical management for BAV-associated aortopathy.
Background:
No medical therapy has been proven to prevent the progression of aortic dilatation in bicuspid aortic valve (BAV) disease, and prophylactic aortic surgery remains the mainstay of treatment.
Hypothesis:
Among patients with BAV disease who are referred for surgery, preoperative statin use is associated with decreased odds of ascending aortic dilatation.
Methods:
We reviewed all BAV patients who underwent aortic valve and/or aortic surgery at our center between April 2004 and December 2013. Aortic diameter (AD), defined as the maximum ascending aortic dimension, was determined by magnetic resonance imaging, computed tomography, or echocardiography. Patients were divided into 2 groups: maximal AD <4.5 cm or ≥4.5 cm. The association between preoperative statin use and aortic dilatation was assessed using multivariable logistic regression modeling.
Results:
Of 680 consecutive patients, 405 (60%) had AD <4.5 cm (mean age, 60 ± 14 years; 45% on statins), whereas 275 (40%) had AD ≥4.5 cm (mean age, 54 ± 13 years; 35% on statins) at the time of surgery. After adjusting for age, body surface area, sex, hypertension, aortic stenosis, severity of aortic regurgitation, and use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and β-blockers, patients with AD ≥4.5 cm had 0.66× lower odds (95% confidence interval: 0.45-0.96) of being on preoperative statins compared with those with AD <4.5 cm (P = 0.029).
Conclusions:
In a retrospective study of BAV patients referred for surgery, preoperative statin use was associated with lower odds of clinically significant ascending aortic dilatation.
Related Concept Videos
Atherosclerosis III: Management
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Aneurysm II: Clinical Manifestations and Diagnostic Studies

